These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22608751)

  • 1. Impact of biological gender and soluble guanylate cyclase stimulation on renal recovery after relief of unilateral ureteral obstruction.
    Wang-Rosenke Y; Mika A; Khadzhynov D; Loof T; Neumayer HH; Peters H
    J Urol; 2012 Jul; 188(1):316-23. PubMed ID: 22608751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of soluble guanylate cyclase improves renal recovery after relief of unilateral ureteral obstruction.
    Wang-Rosenke Y; Mika A; Khadzhynov D; Loof T; Neumayer HH; Peters H
    J Urol; 2011 Sep; 186(3):1142-9. PubMed ID: 21784461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
    Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats.
    Ito K; Chen J; Seshan SV; Khodadadian JJ; Gallagher R; El Chaar M; Vaughan ED; Poppas DP; Felsen D
    Kidney Int; 2005 Aug; 68(2):515-28. PubMed ID: 16014028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease.
    Reinhart GA; Harrison PC; Lincoln K; Chen H; Sun P; Hill J; Qian HS; McHugh MC; Clifford H; Ng KJ; Wang H; Fowler D; Gueneva-Boucheva K; Brenneman JB; Bosanac T; Wong D; Fryer RM; Sarko C; Boustany-Kari CM; Pullen SS
    J Pharmacol Exp Ther; 2023 Mar; 384(3):382-392. PubMed ID: 36507845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
    Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
    Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats.
    Ito K; Chen J; El Chaar M; Stern JM; Seshan SV; Khodadadian JJ; Richardson I; Hyman MJ; Vaughan ED; Poppas DP; Felsen D
    Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1283-93. PubMed ID: 15328069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vas deferens smooth muscle responses to the nitric oxide-independent soluble guanylate cyclase stimulator BAY 41-2272.
    da Silva FH; Claudino MA; Báu FR; Rojas-Moscoso JA; Mónica FZ; De Nucci G; Antunes E
    Eur J Pharmacol; 2012 Aug; 688(1-3):49-55. PubMed ID: 22634166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence.
    Stasch JP; Schlossmann J; Hocher B
    Curr Opin Pharmacol; 2015 Apr; 21():95-104. PubMed ID: 25645316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
    Knorr A; Hirth-Dietrich C; Alonso-Alija C; Härter M; Hahn M; Keim Y; Wunder F; Stasch JP
    Arzneimittelforschung; 2008; 58(2):71-80. PubMed ID: 18412020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery following relief of unilateral ureteral obstruction in the neonatal rat.
    Chevalier RL; Kim A; Thornhill BA; Wolstenholme JT
    Kidney Int; 1999 Mar; 55(3):793-807. PubMed ID: 10027917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble guanylate cyclase stimulator BAY 41-8543 and female sex ameliorate uremic aortic remodeling in a rat model of mild uremia.
    Stancu B; Krämer S; Loof T; Mika A; Amann K; Neumayer HH; Peters H
    J Hypertens; 2015 Sep; 33(9):1907-20; discussion 1921. PubMed ID: 26176653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal nitric oxide synthase and its interaction with soluble guanylate cyclase is a key factor for the vascular dysfunction of experimental sepsis.
    Nardi GM; Scheschowitsch K; Ammar D; de Oliveira SK; Arruda TB; Assreuy J
    Crit Care Med; 2014 Jun; 42(6):e391-400. PubMed ID: 24717470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
    Lee NP; Cheng CY
    Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic guanosine monophosphate-enhancing reduces androgenic extracellular regulated protein kinases-phosphorylation/Rho kinase II-activation in benign prostate hyperplasia.
    Liu CM; Fan YC; Lo YC; Wu BN; Yeh JL; Chen IJ
    Int J Urol; 2014 Jan; 21(1):87-92. PubMed ID: 23692571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats.
    Reyna-Neyra A; Sarkar G; Etgen AM
    J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
    Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra.
    Toque HA; Antunes E; Teixeira CE; De Nucci G
    Urology; 2008 Sep; 72(3):711-5. PubMed ID: 18359064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2006 Jan; 290(1):F167-76. PubMed ID: 16048904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.